All Stories

  1. Prophylactic treatment of bleeding episodes in children <12 years with moderate to severe hereditary factor X deficiency (FXD): Efficacy and safety of a high-purity plasma-derived factor X (pdFX) concentrate

    Article • Haemophilia, April 2018, Wiley

    Miranda Norton

  2. Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in women and girls with hereditary factor X deficiency

    Article • Journal of Thrombosis and Haemostasis, April 2018, Wiley

    Miranda Norton

  3. Experience of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency undergoing surgery

    Article • Haemophilia, May 2016, Wiley

    Miranda Norton

  4. Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency

    Article • Haemophilia, March 2016, Wiley

    Dr Nuria Bermejo, Miranda Norton

  5. Pharmacokinetics of a high-purity plasma-derived factor X concentrate in subjects with moderate or severe hereditary factor X deficiency

    Article • Haemophilia, February 2016, Wiley

    Dr Nuria Bermejo, Miranda Norton